openPR Logo
Press release

Procalcitonin Antibody Market - Size, Share, Outlook, and Forecast till 2026

08-30-2018 03:57 PM CET | Health & Medicine

Press release from: Worldwide Market Reports

Procalcitonin Antibody Market - Size, Share, Outlook,

Procalcitonin (PCT) is a peptide precursor of 116 amino acids produced by parafollicular cells of the thyroid and neuroendocrine cells of lungs and intestine. It is used for synthesis of hormone calcitonin, which is involved in calcium homeostasis. The level of procalcitonin in blood increases as response to bacterial infection. The level of procalcitonin in the blood stream of healthy individuals is below the limit of detection (0.01 µg/L) of clinical assays. Procalcitonin antibodies are used as biomarker that exhibits greater specificity than proinflammatory markers (e.g. cytokines) for diagnosis of patients with sepsis and bacterial infections.

Get Sample copy of research report:

Increasing adoption of procalcitonin antibody for diagnosis of sepsis and other associated disorders is major factor fueling growth of the procalcitonin antibody market. Bacterial or microbial infections results into development of sepsis, which requires effective treatment and prognostic assessment. Conventional clinical laboratory methods for diagnosis of bacterial infections are either non-specific or require longer turnaround times, which is propelling demand for procalcitonin antibodies as biomarker to detect formation of sepsis. Furthermore, procalcitonin antibodies are used for carrying out various research tests such as ELISA, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Sandwich ELISA, and Western Blot, which is driving growth of the procalcitonin antibody market.

Get Best Discount on Research Report:

Key Developments of Procalcitonin Antibody Market

Market players offer procalcitonin antibodies for wide variety of applications in order to meet increasing demand from diagnostic centers and research and development industry. In February 2017, the US Food and Drug Administration (FDA) approved use of a rapid procalcitonin test to determine if antibiotics should be started or stopped in patients with lower respiratory tract infections, such as community-acquired pneumonia and stopped in patients with sepsis. Furthermore, according to the new findings published in Critical Care Medicine, procalcitonin is an effective biomarker for infection and it can be used to determine antibiotic discontinuation in patients with suspected or confirmed sepsis, without causing adverse effects on outcomes.

Market players are engaged in developing novel diagnostics kits in order to maintain leading position in procalcitonin antibody market. In June 2018, Fujirebio Diagnostics received Food and Drug Administration (FDA) clearance for a new procalcitonin assay to be used on its Lumipulse G1200 immunoassay platform.Key players operating in procalcitonin antibody market include Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo, Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, and Hotgen Biotech.

About WMR
Worldwide Market Reports is your one-stop repository of detailed and in-depth market research reports compiled by an extensive list of publishers from across the globe. We offer reports across virtually all domains and an exhaustive list of sub-domains under the sun. The in-depth market analysis by some of the most vastly experienced analysts provide our diverse range of clients from across all industries with vital decision making insights to plan and align their market strategies in line with current market trends. Worldwide Market Research’s well-researched inputs that encompass domains ranging from IT to healthcare enable our prized clients to capitalize upon key growth opportunities and shield against credible threats prevalent in the market in the current scenario and those expected in the near future.

Contact Us:
Mr. Shah
Worldwide Market Reports
1001 4th Ave,
#3200
Seattle, WA 98154,
U.S
Tel: +1 415 871 0703

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Procalcitonin Antibody Market - Size, Share, Outlook, and Forecast till 2026 here

News-ID: 1212765 • Views: 189

More Releases from Worldwide Market Reports

Folding Bicycles Market Brief Analysis of Top Leading Companies From 2021-2026: …
Folding Bicycles Market research report is a detailed analysis of the latest developments, market size, status, future technologies, industry drivers, challenges, regulatory guidelines, key company profiles, and player strategies. According to the research study, this overview of the Folding Bicycles market is a valuable guide and guidance tool for companies and individuals interested in estimating the market size by obtaining key statistics based on the market conditions of the manufacturers.
Smart Building Automation Market Forecast: in-depth Research Shows How Top Compa …
The Global Smart Building Automation Systems Market report provides a comprehensive analysis of key market trends in the global Smart Building Automation Systems Market. It also includes a discussion of historical trends, current market conditions, competitive landscape, growth opportunities, and fact-based challenges. The report quantifies the market share held by major players in the industry and provides an in-depth view of the competitive landscape. In terms of revenue (US$) and
Artificial Intelligence Insight Series - Artificial Intelligence In Telecom Mark …
Global Artificial Intelligence Insight Series - Artificial Intelligence In Telecom Market report 2021 focuses on the industry status, future forecast, growth opportunity, key market, and key players. This study is very useful information for new and growing companies to display themselves in the market. Additionally, the report offers an in-depth analysis of Artificial Intelligence Insight Series - Artificial Intelligence In Telecom industry size, share, growth, segment, manufacturers and advancements, key
Human Growth Hormone Market: Development - Opportunities in Future, Growth Forec …
This Analytical study offer in-depth analysis concerning the complete Human Growth Hormone Market position and Recent Trends. worldwide market reports provide detailed Market Statistics, including Product types, Top Manufacturers, Market CAGR Status, and favorable factors that are expected to drive the Growth rate of the Human Growth Hormone Market with SWOT Analysis. Get More Information on this Report: https://www.worldwidemarketreports.com/sample/619133 The Human Growth Hormone market report offers clear-cut information about the key business

All 5 Releases


More Releases for Procalcitonin

Procalcitonin Antibody Market Size, Share, Development by 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Procalcitonin Antibody market. Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine cells of the lung. Under normal expression conditions, procalcitonin is immediately cleaved into three specific fragments, an N terminal residue,
Procalcitonin Antibody Market Report 2018: Segmentation by Type (Polyclonal Proc …
Global Procalcitonin Antibody market research report provides company profile for Ningbo Medicalsystem Biotechnology, Snibe, Vazyme Biotech, Getein Biotech, Hotgen Biotech, Lumigenex, Shanghai Medicine'nest Pharmaceutical, Thermo Fisher, Roche Diagnostics, bioMerieux, HyTest, Wondfo and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for
Procalcitonin Antibody Market - Size, Share, Outlook, and Forecast till 2026
Procalcitonin (PCT) is a peptide precursor of 116 amino acids produced by parafollicular cells of the thyroid and neuroendocrine cells of lungs and intestine. It is used for synthesis of hormone calcitonin, which is involved in calcium homeostasis. The level of procalcitonin in blood increases as response to bacterial infection. The level of procalcitonin in the blood stream of healthy individuals is below the limit of detection (0.01 µg/L) of
Procalcitonin Antibody Market Outlook, and Opportunity Analysis, 2018 - 2026
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin
Procalcitonin Antibody Market Opportunity Analysis, 2018 - 2026
Procalcitonin (PCT) is a peptide precursor of the hormone calcitonin, and belongs to calcitonin (CT) superfamily of peptides. Procalcitonin is a 116 amino acid peptide that has an estimated molecular weight of 14.5 kDa. It can be segregated into three parts, namely immature calcitonin, calcitonin carboxyl-terminus peptide-1, and amino terminus of the PCT region. Procalcitonin was first classified by Bernard Roos and Leonard J. Deftos in the early 1970s. Procalcitonin
China Procalcitonin Market by Type and Application, Forecast To 2022
MarketResearchNest.com adds “China Procalcitonin (CAS 56645-65-9) Market by Manufacturers, Regions (Province), Type And Application, Forecast To 2022” new report to its research database. The report spread across in a 116 pages with table and figures in it. Procalcitonin (PCT) is a 116 amino acid residue protein with a molecular weight of approximately 13kDa. Procalcitonin is a peptide hormone mainly produced by the C cells of the thyroid and certain endocrine